MedTrace Logo

North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)

NCT02564120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1556

Last updated 2020-04-28

Study results available
· View outcomes & findings →

Summary

NC ProCESS is a cohort of patients from diverse backgrounds diagnosed with early prostate cancer, who were enrolled from January 2011-June 2013. These patients were recruited throughout North Carolina, and also in partnership with institutions across the country. Patients enrolled before they start treatment, and are then followed prospectively through treatment and then afterwards. This observational study collects information on quality of life, cancer control, and health care received inclusive of treatment and management of subsequent effects including complications and recurrence. The objective of this study is to examine comparative outcomes among different modern prostate cancer treatment options in this cohort of patients.

Conditions

  • Cancer of Prostate
  • Cancer of the Prostate
  • Prostate Cancer
  • Prostatic Cancer

Sponsors & Collaborators

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02564120 on ClinicalTrials.gov